STOCK TITAN

PACS Group (PACS) COO sells 36,335 shares around $34 level

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. President & COO Joshua Jergensen reported an open-market sale of common stock. On March 13, 2026, he sold 36,335 shares of PACS Group common stock at a weighted average price of $34.2823 per share.

The shares were sold in multiple trades at prices ranging from $34.28 to $34.3301 per share, according to the footnote. After these transactions, Jergensen directly owns 2,667,347 shares of PACS Group common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jergensen Joshua

(Last) (First) (Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700

(Street)
SALT LAKE CITY UT 84101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President & COO
3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/13/2026 S 36,335 D $34.2823(1) 2,667,347 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $34.28 to $34.3301, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ John Mitchell, Attorney-in-Fact 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PACS (PACS) disclose in this Form 4?

PACS Group disclosed that President & COO Joshua Jergensen sold 36,335 shares of common stock. The open-market sale occurred on March 13, 2026, and was reported as a routine insider transaction in common stock.

At what price did Joshua Jergensen sell PACS (PACS) shares?

The filing reports a weighted average sale price of $34.2823 per share. A footnote explains the shares were sold in multiple trades, with individual prices ranging from $34.28 to $34.3301 per share during the same trading day.

How many PACS (PACS) shares does Joshua Jergensen hold after the sale?

After the reported sale, Joshua Jergensen directly owns 2,667,347 shares of PACS Group common stock. This remaining stake, disclosed in the Form 4, indicates he continues to hold a substantial ownership position in the company following the transaction.

Was the PACS (PACS) insider transaction an open-market sale or another type?

The Form 4 characterizes the transaction as an open-market sale of common stock. It uses SEC transaction code “S,” which the filing describes as a sale in open market or private transaction, rather than a grant, option exercise, or tax-related withholding.

Does the PACS (PACS) Form 4 mention a price range for the sold shares?

Yes. A footnote states the shares were sold in multiple transactions at prices between $34.28 and $34.3301, inclusive. The reported $34.2823 figure is a weighted average price across those individual trades executed on March 13, 2026.
PACS Group

NYSE:PACS

View PACS Stock Overview

PACS Rankings

PACS Latest News

PACS Latest SEC Filings

PACS Stock Data

5.44B
44.84M
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
SALT LAKE CITY